Literature DB >> 25373852

Increased circulating RANTES in type 2 diabetes.

Marzena Dworacka1, Ewa Krzyżagórska2, Saule Iskakova3, Yerbol Bekmukhambetov4, Olzhas Urazayev4, Grzegorz Dworacki5.   

Abstract

AIM: The pro-atherogenic role of RANTES, a chemokine expressing pleiotropic activities, in the course of type 2 diabetes-related atherosclerosis has been well documented. However, it is not known which of the diabetes-related factors primarily influence serum RANTES levels in patients with type 2 diabetes. Our aim was to investigate relationships between several factors known to be related to an increased risk of atherosclerosis and serum RANTES levels in type 2 diabetic patients.
METHODS: A total of 168 subjects were examined, which included 138 patients with type 2 diabetes and 30 non-diabetic controls. Measurements of venous, fasting, plasma glucose, HbA1c, lipid profile, 1,5-anhydro-D-glucitol (1,5-AG) plasma levels, homocysteine and the fasting, serum C-peptide levels were performed. Serum concentrations of RANTES were assayed using BD(TM) Cytometric Bead Array tests. Peripheral insulin resistance was expressed according to a new index defined by Ohkura et al.
RESULTS: RANTES levels in type 2 diabetic patients correlated with 1,5-AG, fasting glycaemia, HbA1c and the Ohkura index. Multivariate regression analysis was performed taking into consideration several factors related to the inflammatory process and atherosclerosis, namely the patient's age, diabetes duration, waist circumference, 1,5-AG, HbA1c, lipid profile parameters, serum homocysteine levels and Ohkura index, as independent variables potentially influencing serum RANTES levels in type 2 diabetic patients. It is shown that RANTES concentrations in the serum is primarily dependent upon 1,5-AG plasma levels.
CONCLUSION: Our results suggest that increased serum levels of RANTES in type 2 diabetic patients are closely related to postprandial (acute) hyperglycaemia.

Entities:  

Keywords:  1; 5-anhydro-D-glucitol; RANTES; postprandial hyperglycaemia; type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25373852     DOI: 10.1684/ecn.2014.0355

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  8 in total

1.  Integrated computational approaches to screen gene expression data to determine key genes and therapeutic targets for type-2 diabetes mellitus.

Authors:  Fahad A Alhumaydhi
Journal:  Saudi J Biol Sci       Date:  2022-02-10       Impact factor: 4.052

2.  Anti-inflammatory properties of bone morphogenetic protein 4 in human adipocytes.

Authors:  E Baraban; T Chavakis; B S Hamilton; S Sales; M Wabitsch; S R Bornstein; M Ehrhart-Bornstein
Journal:  Int J Obes (Lond)       Date:  2015-07-31       Impact factor: 5.095

3.  Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study.

Authors:  Xiaomeng Feng; Xia Gao; Yumei Jia; Heng Zhang; Yuan Xu
Journal:  Diabetes Ther       Date:  2017-01-24       Impact factor: 2.945

4.  Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer's disease.

Authors:  Gabriela Vacinova; Daniela Vejražkova; Robert Rusina; Iva Holmerová; Hana Vaňková; Eva Jarolímová; Josef Včelák; Běla Bendlová; Markéta Vaňková
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

Review 5.  DPP4 in Diabetes.

Authors:  Diana Röhrborn; Nina Wronkowitz; Juergen Eckel
Journal:  Front Immunol       Date:  2015-07-27       Impact factor: 7.561

6.  PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.

Authors:  Xiaomeng Feng; Xia Gao; Yumei Jia; Heng Zhang; Yuan Xu; Guang Wang
Journal:  Med Sci Monit       Date:  2016-03-05

7.  Increased Adipose Tissue Expression of Interferon Regulatory Factor (IRF)-5 in Obesity: Association with Metabolic Inflammation.

Authors:  Sardar Sindhu; Reeby Thomas; Shihab Kochumon; Ajit Wilson; Mohamed Abu-Farha; Abdullah Bennakhi; Fahd Al-Mulla; Rasheed Ahmad
Journal:  Cells       Date:  2019-11-11       Impact factor: 6.600

Review 8.  The Chemokine Systems at the Crossroads of Inflammation and Energy Metabolism in the Development of Obesity.

Authors:  Pei-Chi Chan; Po-Shiuan Hsieh
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.